This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Martin, C. N. Articles by Kadlubar, F. F. Search for Related Content PubMed PubMed Citation Articles by Martin, C. N. Articles by Kadlubar, F. F.

Covalent Binding of Benzidine and N-Acetylbenzidine to DNA at the C-8 Atom of Deoxyguanosine in Vivo and in Vitro¹

National Center for Toxicological Research, Food and Drug Administration, Jefferson, Arkansas 72079 [C. N. M., F. A. B., F. F. K.], and Midwest Research Institute, Kansas City, Missouri 64110 [R. W. R.]

Benzidine, a human urinary bladder carcinogen, induces hepatic tumors in mice and rats. In this study, [³H]benzidine was administered in drinking water to mice for 1 week, and the covalent binding of the carcinogen to hepatic DNA was then determined. A single carcinogen:DNA adduct was detected which decreased in concentration by 50% at 1 day after treatment and then remained at a nearly constant level for at least 7 days. Injection of radiolabeled benzidine or N-acetylbenzidine into rats also resulted in a single carcinogen:DNA adduct that was chromatographically identical to that obtained in mouse liver. While administration of benzidine and N-acetylbenzidine resulted in high levels of the adduct in rat hepatic DNA, injection of N,N'-[ring-¹⁴C]diacetylbenzidine did not give detectable binding (<0.3 residue/mg DNA).

The same carcinogen:DNA adduct found in rat and mouse liver was prepared synthetically by: (a) hydrolysis of calf thymus DNA reacted with N-hydroxy-N'-acetylbenzidine at pH 5; and (b) reaction of N-acetoxy-N,N'-diacetylbenzidine with deoxyguanosine and subsequent selective deacetylation of the product with methanolic ammonia. The in vitro and in vivo products were found to have identical high-pressure liquid chromatography retention times and to exhibit similar pH-dependent solvent partitioning characteristics. Mass and nuclear magnetic resonance spectral data of the synthetic products established the structure of the hepatic adduct as N-(deoxyguanosin-8-yl)-N'-acetylbenzidine. The structural isomer, N-(deoxyguanosin-8-yl)-N-acetylbenzidine, was synthesized by treatment of N-(deoxyguanosin-8-yl)-N,N'-diacetylbenzidine (the intermediate in b) with carboxylesterase and was shown to be chromatographically distinct from the in vivo adduct. Similarly, the nonacetylated derivative, N-(deoxyguanosin-8-yl)benzidine, was synthesized by carboxylesterase treatment of N-(deoxyguanosin-8-yl)-N'-acetylbenzidine and was shown not to occur in rat and mouse liver DNA.

These data indicate that the metabolic activation of benzidine to an ultimate carcinogen in rats and mice does not involve N-hydroxybenzidine or sulfotransferase-catalyzed activation of N-hydroxy-N,N'-diacetylbenzidine. The remaining pathways for metabolic conversion of benzidine to an ultimate carcinogenic species are discussed in relation to liver and urinary bladder carcinogenesis.

¹ For simplicity, throughout this manuscript the nitrogen atom of benzidine through which binding to deoxyguanosine occurs has been designated as the nonprime nitrogen.

² Visiting Scientist, United States Food and Drug Administration. To whom requests for reprints should be addressed, at Cancer Research Unit, University of York, York Y01 5DD, United Kingdom.

Received 12/ 4/81. Accepted 4/ 8/82.

This article has been cited by other articles:

				S.-C. Chen, C.-M. Kao, M.-H. Huang, M.-K. Shih, Y.-L. Chen, S.-P. Huang, and T.-Z. Liu Assessment of Genotoxicity of Benzidine and Its Structural Analogues to Human Lymphocytes Using Comet Assay Toxicol. Sci., April 1, 2003; 72(2): 283 - 288. [Abstract] [Full Text] [PDF]

				V. M. Lakshmi, F. F. Hsu, A. E. McGarry, B. B. Davis, and T. V. Zenser Hypochlorous Acid-Mediated Activation of N-acetylbenzidine to Form N'-(3'-monophospho-deoxyguanosin-8-yl)-N-acetylbenzidine Toxicol. Sci., February 1, 2000; 53(2): 202 - 212. [Abstract] [Full Text] [PDF]

				T. V. Zenser, V. M. Lakshmi, F. F. Hsu, and B. B. Davis Peroxygenase Metabolism of N-Acetylbenzidine by Prostaglandin H Synthase. FORMATION OF AN N-HYDROXYLAMINE J. Biol. Chem., May 21, 1999; 274(21): 14850 - 14856. [Abstract] [Full Text] [PDF]

				T. V. Zenser, V. M. Lakshmi, and B. B. Davis N-Glucuronidation of Benzidine and Its Metabolites. Role in Bladder Cancer Drug Metab. Dispos., September 1, 1998; 26(9): 856 - 859. [Abstract] [Full Text]

				V. M. Lakshmi, T. V. Zenser, and B. B. Davis Rat Liver Cytochrome P450 Metabolism of N-Acetylbenzidine and N,N'-Diacetylbenzidine Drug Metab. Dispos., April 1, 1997; 25(4): 481 - 488. [Abstract] [Full Text]